(Q35672977)

9 August 2017

1 reference

25 April 2019

Defining the differences between episodic migraine and chronic migraine (English)

1 reference

9 August 2017

1 reference

25 April 2019

4

Richard B Lipton

1 reference

9 August 2017

2

Dawn C Buse

1 reference

9 August 2017

1

Zaza Katsarava

1 reference

9 August 2017

Aubrey N Manack

3

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 February 2012

2 references

Current Pain and Headache Reports

9 August 2017

25 April 2019

2 references

9 August 2017

25 April 2019

16

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

86-92

1 reference

Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258393

OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258393

Current practice and future directions in the prevention and acute management of migraine

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258393

Employment and work impact of chronic migraine and episodic migraine

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258393

Tracing transformation: chronic migraine classification, progression, and epidemiology

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258393

Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258393

Concepts and mechanisms of migraine chronification

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258393

The global burden of headache: a documentation of headache prevalence and disability worldwide

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258393

Modifiable risk factors for migraine progression

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258393

New appendix criteria open for a broader concept of chronic migraine

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258393

Medication-overuse headache: a worldwide problem

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258393

Incidence and predictors for chronicity of headache in patients with episodic migraine

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258393

The International Classification of Headache Disorders: 2nd edition

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258393

Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258393

The PHQ-9: validity of a brief depression severity measure

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258393

Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study

27 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0233-Z

Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0233-Z

Migraine prevalence, disease burden, and the need for preventive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0233-Z

Prevalence and characteristics of allodynia in headache sufferers: a population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0233-Z

Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0233-Z

The face of chronic migraine: epidemiology, demographics, and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0233-Z

Depression and anxiety: effect on the migraine-obesity relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0233-Z

Caffeine as a risk factor for chronic daily headache: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0233-Z

Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0233-Z

Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0233-Z

Treatment of Chronic Migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0233-Z

Major Life Changes Before and After the Onset of Chronic Daily Headache: A Population-Based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0233-Z

Chronic Daily Headache in Taipei, Taiwan: Prevalence, Follow-Up and Outcome Predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0233-Z

Conceptualizing the relationship between chronic migraine and episodic migraine

21 January 2018

1 reference

12 December 2020

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

1 reference

12 December 2020

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

1 reference

12 December 2020

Rates, predictors, and consequences of remission from chronic migraine to episodic migraine

1 reference

12 December 2020

Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up

1 reference

12 December 2020

Comorbidity of migraine and depression: investigating potential etiology and prognosis

1 reference

12 December 2020

Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society

1 reference

12 December 2020

Classification of daily and near-daily headaches: field trial of revised IHS criteria

1 reference

12 December 2020

Obesity is a risk factor for transformed migraine but not chronic tension-type headache

1 reference

12 December 2020

10.1007/S11916-011-0233-Z

Identifiers

DOI

1 reference

9 August 2017

1 reference

9 August 2017

1 reference